Mycophenolate mofetil for scleroderma-related interstitial lung disease: A real world experience

MLA

Ashima Makol, et al. “Mycophenolate Mofetil for Scleroderma-Related Interstitial Lung Disease: A Real World Experience.” PLoS ONE, vol. 12, no. 5, Jan. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f6bce384922cff6ff9e0ed696d383e28&authtype=sso&custid=ns315887.

APA

Ashima Makol, Jay H. Ryu, Brian J. Bartholmai, Misbah Baqir, & Thomas G. Osborn. (2017). Mycophenolate mofetil for scleroderma-related interstitial lung disease: A real world experience. PLoS ONE, 12(5).

Chicago

Ashima Makol, Jay H. Ryu, Brian J. Bartholmai, Misbah Baqir, and Thomas G. Osborn. 2017. “Mycophenolate Mofetil for Scleroderma-Related Interstitial Lung Disease: A Real World Experience.” PLoS ONE 12 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f6bce384922cff6ff9e0ed696d383e28&authtype=sso&custid=ns315887.